Pancreatic cancer is a dismal disease. The 5-years overall survival ranges from 1% to 5%. Surgery is the only curative treatment available. Survival of selected patients with small lesion (< 2 cm) confined to the pancreas is improved to 19-41%. Presently the major effort is on studies of the cancer development phenomena to improve detection of patients with early lesions. The analysis of oncogene and tumor-suppressor gene activation may enable us to better define and cure this disease. Molecular genetic new tecnquiques performed on pancreatic juice, duodenal juice and stool, probably are the most promising new approach for early diagnosis of pancreatic cancer. This could be the right path to diagnose pancreatic malignant lesions at a curable stage, and to discriminate patients with a more favourable prognosis candidates to be submitted to adjuvant therapy with a curative intent, and also to discriminate real pancreatic cancer from patients with chronic pancreatitis.

Le anomalie genetiche del carcinoma pancreatico e le applicazioni cliniche [Genetic anomalies of pancreatic carcinoma and clinical applications] / Pantalone, D; Pelo, E; Minuti, B; Mazza, E; Nesi, G; Falchini, M; Ragionieri, I; Pantalone, F; Torricelli, F. - In: LA CLINICA TERAPEUTICA. - ISSN 0009-9074. - STAMPA. - 152:(2001), pp. 189-196.

Le anomalie genetiche del carcinoma pancreatico e le applicazioni cliniche [Genetic anomalies of pancreatic carcinoma and clinical applications]

PANTALONE, DESIRE'
Writing – Original Draft Preparation
;
PELO, ELISABETTA
Writing – Review & Editing
;
MAZZA, ELENA
Investigation
;
FALCHINI, MASSIMO
Investigation
;
TORRICELLI, FRANCESCA
2001

Abstract

Pancreatic cancer is a dismal disease. The 5-years overall survival ranges from 1% to 5%. Surgery is the only curative treatment available. Survival of selected patients with small lesion (< 2 cm) confined to the pancreas is improved to 19-41%. Presently the major effort is on studies of the cancer development phenomena to improve detection of patients with early lesions. The analysis of oncogene and tumor-suppressor gene activation may enable us to better define and cure this disease. Molecular genetic new tecnquiques performed on pancreatic juice, duodenal juice and stool, probably are the most promising new approach for early diagnosis of pancreatic cancer. This could be the right path to diagnose pancreatic malignant lesions at a curable stage, and to discriminate patients with a more favourable prognosis candidates to be submitted to adjuvant therapy with a curative intent, and also to discriminate real pancreatic cancer from patients with chronic pancreatitis.
2001
152
189
196
Goal 3: Good health and well-being
Pantalone, D; Pelo, E; Minuti, B; Mazza, E; Nesi, G; Falchini, M; Ragionieri, I; Pantalone, F; Torricelli, F
File in questo prodotto:
File Dimensione Formato  
Anomalie genetiche pancreas 2001_0001.pdf

accesso aperto

Descrizione: Studio sulle alterazioni genetiche specifiche per il cancro del pancreas , nella bile dei pazienti sottoposti ad detensione percultanea delle vie biliari
Tipologia: Pdf editoriale (Version of record)
Licenza: Open Access
Dimensione 4.39 MB
Formato Adobe PDF
4.39 MB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1060258
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact